000099155 001__ 99155
000099155 005__ 20240109134257.0
000099155 0247_ $$2doi$$a10.3390/nu13010084
000099155 0248_ $$2sideral$$a122626
000099155 037__ $$aART-2021-122626
000099155 041__ $$aeng
000099155 100__ $$0(orcid)0000-0002-7758-3588$$aSanz-Paris, A.$$uUniversidad de Zaragoza
000099155 245__ $$aImpact of an oral nutritional protocol with oligomeric enteral nutrition on the quality of life of patients with oncology treatment-related diarrhea
000099155 260__ $$c2021
000099155 5060_ $$aAccess copy available to the general public$$fUnrestricted
000099155 5203_ $$aBackground: Nutritional status can influence the quality of life (QoL) of cancer patients.
Methods: This subanalysis evaluated the impact of an oral oligomeric enteral nutrition (OEN) protocol on the QoL of patients with oncology treatment-related diarrhea (OTRD) in a multicenter, observational, prospective study (DIAPOENO study). QoL was assessed with the Nottingham Health Profile (NHP) at baseline and after eight weeks of OEN treatment.
In the overall population, all the NHP categories significantly improved after eight weeks of OEN treatment: energy levels (p < 0.001), pain (p < 0.001), emotional reactions (p < 0.001), sleep (p < 0.001), social isolation (p = 0.023), and physical abilities (p = 0.001). QoL improvement was higher in patients with improved or maintained nutritional status and in those with improved consistency of stools with the OEN protocol. However, QoL did not significantly improve in patients with worse nutritional status and with worse or maintained stool consistency with the OEN protocol. QoL improved regardless of disease severity. Multivariate logistic regression analysis showed that weight change was significantly associated with improved QoL (OR 2.90–5.3), except for social isolation, in models unadjusted and adjusted to age, sex, oncology treatment, and stool consistency.
Conclusion: In this subanalysis, the OEN protocol was associated with improved QoL.
000099155 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000099155 590__ $$a6.706$$b2021
000099155 592__ $$a1.287$$b2021
000099155 594__ $$a7.9$$b2021
000099155 591__ $$aNUTRITION & DIETETICS$$b15 / 90 = 0.167$$c2021$$dQ1$$eT1
000099155 593__ $$aNutrition and Dietetics$$c2021$$dQ1
000099155 593__ $$aFood Science$$c2021$$dQ1
000099155 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000099155 700__ $$aMartinez-Trufero, J.
000099155 700__ $$0(orcid)0000-0003-0063-1067$$aLambea-Sorrosal, J.$$uUniversidad de Zaragoza
000099155 700__ $$aMilà-Villarroel, R.
000099155 700__ $$0(orcid)0000-0001-7774-8840$$aCalvo-Gracia, F.$$uUniversidad de Zaragoza
000099155 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina
000099155 773__ $$g13, 1 (2021), 84 [13 pp]$$pNutrients$$tNutrients$$x2072-6643
000099155 8564_ $$s473586$$uhttps://zaguan.unizar.es/record/99155/files/texto_completo.pdf$$yVersión publicada
000099155 8564_ $$s2721698$$uhttps://zaguan.unizar.es/record/99155/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000099155 909CO $$ooai:zaguan.unizar.es:99155$$particulos$$pdriver
000099155 951__ $$a2024-01-09-13:33:36
000099155 980__ $$aARTICLE